div class=ts-pagebuttonPage 1button div class=ts-image amp-img class=ts-thumb alt=Page 1: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 2button div class=ts-image amp-img class=ts-thumb alt=Page 2: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divp•pdivdiv class=ts-pagebuttonPage 3button div class=ts-image amp-img class=ts-thumb alt=Page 3: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 4button div class=ts-image amp-img class=ts-thumb alt=Page 4: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 5button div class=ts-image amp-img class=ts-thumb alt=Page 5: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails5jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 6button div class=ts-image amp-img class=ts-thumb alt=Page 6: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails6jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 7button div class=ts-image amp-img class=ts-thumb alt=Page 7: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails7jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 8button div class=ts-image amp-img class=ts-thumb alt=Page 8: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails8jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 9button div class=ts-image amp-img class=ts-thumb alt=Page 9: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails9jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 10button div class=ts-image amp-img class=ts-thumb alt=Page 10: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails10jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 11button div class=ts-image amp-img class=ts-thumb alt=Page 11: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails11jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 12button div class=ts-image amp-img class=ts-thumb alt=Page 12: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails12jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 13button div class=ts-image amp-img class=ts-thumb alt=Page 13: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails13jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 14button div class=ts-image amp-img class=ts-thumb alt=Page 14: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails14jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 15button div class=ts-image amp-img class=ts-thumb alt=Page 15: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails15jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 16button div class=ts-image amp-img class=ts-thumb alt=Page 16: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails16jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 17button div class=ts-image amp-img class=ts-thumb alt=Page 17: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails17jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 18button div class=ts-image amp-img class=ts-thumb alt=Page 18: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails18jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 19button div class=ts-image amp-img class=ts-thumb alt=Page 19: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails19jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 20button div class=ts-image amp-img class=ts-thumb alt=Page 20: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails20jpg width=142 height=106 layout=responsive amp-img divp pdivdiv class=ts-pagebuttonPage 21button div class=ts-image amp-img class=ts-thumb alt=Page 21: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails21jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 22button div class=ts-image amp-img class=ts-thumb alt=Page 22: PowerPoint-Präsentationfilesthinkpoolcomfilesbbs20161128 · Marktdaten AG Pro Biosimilars 092016 ODD* gesamt patentgeschützte Biopharmazeutika patentfreie Biopharmazeutika src=https:reader036vdokumentcomreader036viewer20220707235f01f9d67e708231d401f621html5thumbnails22jpg width=142 height=106 layout=responsive amp-img divdiv